Related Experiment Video
Updated: Jul 24, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Effects of Chinese, Japanese and Western tea on hepatic P450 enzyme activities in rats
N Niwattisaiwong1, X X Luo, P F Coville
1Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Abstract:
Previous studies have reported that green tea effectively protects against cancers caused by various dietary carcinogens. As P450 enzymes are the major system responsible for the metabolism of many carcinogens, we hypothesise that tea consumption may alter the catalytic activities of P450 enzymes. We conducted this study to screen the effects of four different teas on the activities of P450 enzymes. Tea solutions (2.5%) were prepared by adding boiling water to tea leaves and filtering. Female Wistar rats were divided into five groups (n = 4 each); each had free access to tea solutions while the control group was supplied with water for 4 weeks. Animals were sacrificed and livers were removed for preparation of microsomes. Enzyme activities were determined by incubation of liver microsomes with the appropriate CYP substrate. The activity of CYP1A1 in livers from rats receiving Oolong (Chinese) tea (185 +/- 63 pmol/mg/min), Japanese green tea (197 +/- 22 pmol/mg/min) and Earl Grey tea (228 +/- 40 pmol/mg/min) was significantly higher (p < 0.05) than in the control group (94 +/- 34 pmol/mg/min), whereas no change was observed in the activity of CYP1A2 in any of tested animals. The hepatic activity of CYP2D6 was greater only in rats drinking Earl Grey tea compared to the controls (235 +/- 37 vs 161 +/- 41 pmol/mg/min, p < 0.05). There were also significant increases (p < 0.05) in the activity of CYP3A in livers of animals given Oolong tea (653 +/- 174 vs 382 +/- 114 pmol/mg/min) and Earl Grey tea (751 +/- 202 pmol/mg/min), while Jasmine and Japanese green tea had no significant effect. These results indicate that not all types of tea cause alterations in liver CYP enzymes as some elevated activities and some did not. Further studies are needed to determine whether there is a relationship between the effect of tea on CYP activities and anti-carcinogenesis.
Insights
Certain teas, like Earl Grey and Oolong, significantly alter liver cytochrome P450 (CYP) enzyme activity in rats. This suggests varied effects of tea consumption on carcinogen metabolism, warranting further anti-cancer research.
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
- Nutritional Science
Background:
- Green tea consumption is linked to cancer protection against dietary carcinogens.
- Cytochrome P450 (CYP) enzymes are crucial for metabolizing many carcinogens.
- The impact of different tea types on CYP enzyme activity remains largely uncharacterized.
Purpose of the Study:
- To investigate the effects of four distinct teas on the catalytic activities of specific liver CYP enzymes.
- To determine if tea consumption influences the metabolic pathways involved in carcinogen detoxification.
Main Methods:
- Preparation of 2.5% tea solutions from Oolong, Japanese green, Earl Grey, and Jasmine teas.
- Administration of tea solutions or water to female Wistar rats for 4 weeks.
- Analysis of liver microsomes to determine the activity of CYP1A1, CYP1A2, CYP2D6, and CYP3A enzymes.
Main Results:
- Oolong, Japanese green, and Earl Grey teas significantly increased CYP1A1 activity compared to controls.
- Earl Grey tea notably elevated CYP2D6 activity, while Oolong and Earl Grey teas significantly enhanced CYP3A activity.
- Jasmine and Japanese green teas showed no significant impact on CYP3A activity, and no tested tea altered CYP1A2 activity.
Conclusions:
- Different tea varieties exert differential effects on liver CYP enzyme activities.
- Specific teas, such as Earl Grey and Oolong, can modulate key enzymes involved in xenobiotic metabolism.
- Further research is necessary to correlate these observed changes in CYP activity with tea's potential anti-carcinogenic properties.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

